SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-005615
Filing Date
2022-02-28
Accepted
2022-02-28 16:32:31
Documents
1
Period of Report
2022-02-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3943
  Complete submission text file 0001493152-22-005615.txt   5308
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21925 W FIELD PARKWAY, SUITE 235 DEER PARK IL 60010
Business Address
Troutman William Wilson (Reporting) CIK: 0001756102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38738 | Film No.: 22690250